Scientifically engineered for dynamic performance, the Alere Determine™ rapid tests allow the screening and support in the detection of HIV, tuberculosis, hepatitis B, and syphilis in just 25 minutes. This point-of-care platform requires minimal training, can be easily stored and transported. It is ideal for any setting.

Alere Determine™ HBsAg

By detecting early markers of Hepatitis B infection, the Alere Determine™ HBsAg helps to diagnose acute infection and confirm chronic infection - allowing healthcare professionals to initiate prompt and appropriate follow-up action for infected patients.

Alere Determine™ HIV-1/2

By detecting all known subtypes of HIV, Alere Determine™ HIV-1/2 will help healthcare workers across the world diagnose individual infection, prevent mother-to-child transmission, monitor HIV prevalence and screen blood donations.

Alere Determine™ HIV-1/2 Ag/Ab Combo

Every day counts – now you can help identify HIV just days after infection. The Alere Determine™ HIV Combo empowers you at the point-of-care, to diagnose HIV earlier than ever before.

Alere Determine™ Syphilis

Syphilis is caused by the organism Treponema pallidum and is usually transmitted via sexual contact; it can also be transmitted from mother to child (congenital syphilis).

Alere Determine™ TB LAM Ag

Rapid Rule-in TB-HIV Co-infection. Now there is a new advantage to help detect active Tuberculosis (TB) in the HIV community. The Alere Determine™ TB LAM Ag test empowers you, at the point-of-care, to screen for active TB in HIV positive patients, providing results in just minutes.

For more detail: https://www.news-medical.net/ads/abmc.aspx?b=1916